WO2023037358 - PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS
National phase entry:
Publication Number
WO/2023/037358
Publication Date
16.03.2023
International Application No.
PCT/IL2022/050937
International Filing Date
29.08.2022
Title **
[English]
PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS
[French]
TRAITEMENT DE CELLULES PLACENTAIRES POUR DES SOUS-POPULATIONS DE PATIENTS À ISCHÉMIE CRITIQUE DES MEMBRES
Applicants **
PLURI BIOTECH LTD.
Inventors
ROTHENSTEIN, Daniel
MATHEWS, Yuval
Priority Data
63/242,087
09.09.2021
US
63/251,702
04.10.2021
US
63/283,615
29.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
ILPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2961 | |
| EPO | Filing, Examination, Granting | 18930 | |
| Japan | Filing, Examination, Granting | 2511 | |
| South Korea | Filing, Examination, Granting | 2897 | |
| USA | Filing, Examination, Granting | 8940 |
Total:
36,239
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are methods and compositions comprising placental adherent stromal cells for treating peripheral ischemic disease, for example critical limb ischemia in specific patient subpopulations; and methods of selecting subjects having peripheral ischemic disease, for example critical limb ischemia, amenable for treatment with placental adherent stromal cells.[French]
L'invention concerne des méthodes et des compositions comprenant des cellules stromales adhérentes placentaires destinées à traiter une maladie ischémique périphérique, par exemple une ischémie critique des membres chez des sous-populations de patients spécifiques ; et des méthodes de sélection de sujets souffrant d'une maladie ischémique périphérique, par exemple une ischémie critique des membres, pouvant être traités avec des cellules stromales adhérentes placentaires.